Barclays PLC Paratek Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.73 - $3.09 $13,756 - $24,571
-7,952 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.94 - $4.77 $151,395 - $245,631
-51,495 Reduced 86.62%
7,952 $24,000
Q4 2021

Feb 14, 2022
BUY
$4.07 - $5.3 $162,470 - $211,570
39,919 Added 204.42%
59,447 $267,000
Q3 2021

Nov 09, 2021
BUY
$4.7 - $7.24 $62,378 - $96,089
13,272 Added 212.15%
19,528 $94,000
Q2 2021

Aug 13, 2021
SELL
$6.81 - $10.93 $426,673 - $684,808
-62,654 Reduced 90.92%
6,256 $42,000
Q1 2021

May 13, 2021
BUY
$6.14 - $8.31 $137,843 - $186,559
22,450 Added 48.32%
68,910 $486,000
Q4 2020

Feb 11, 2021
SELL
$4.58 - $7.14 $25,455 - $39,684
-5,558 Reduced 10.68%
46,460 $291,000
Q3 2020

Nov 12, 2020
SELL
$4.19 - $6.69 $10,592 - $16,912
-2,528 Reduced 4.63%
52,018 $281,000
Q2 2020

Aug 12, 2020
BUY
$2.97 - $5.22 $129,239 - $227,148
43,515 Added 394.48%
54,546 $285,000
Q1 2020

May 13, 2020
SELL
$2.67 - $4.97 $58,654 - $109,180
-21,968 Reduced 66.57%
11,031 $34,000
Q4 2019

Feb 10, 2020
BUY
$2.93 - $4.5 $48,470 - $74,443
16,543 Added 100.53%
32,999 $133,000
Q3 2019

Nov 14, 2019
SELL
$3.08 - $5.76 $15,048 - $28,143
-4,886 Reduced 22.89%
16,456 $71,000
Q2 2019

Aug 14, 2019
BUY
$3.47 - $6.32 $41,313 - $75,245
11,906 Added 126.18%
21,342 $85,000
Q1 2019

May 15, 2019
BUY
$5.36 - $7.24 $37,171 - $50,209
6,935 Added 277.29%
9,436 $51,000
Q4 2018

Feb 14, 2019
SELL
$4.8 - $11.6 $45,475 - $109,898
-9,474 Reduced 79.11%
2,501 $13,000
Q3 2018

Nov 14, 2018
BUY
$9.05 - $10.95 $86,979 - $105,240
9,611 Added 406.56%
11,975 $117,000
Q2 2018

Aug 14, 2018
SELL
$10.2 - $13.9 $36,138 - $49,247
-3,543 Reduced 59.98%
2,364 $24,000
Q1 2018

May 15, 2018
SELL
$12.65 - $18.85 $160,629 - $239,357
-12,698 Reduced 68.25%
5,907 $77,000
Q4 2017

Feb 14, 2018
BUY
$17.45 - $25.6 $907 - $1,331
52 Added 0.28%
18,605 $333,000
Q3 2017

Nov 14, 2017
BUY
$18.9 - $28.2 $350,651 - $523,194
18,553
18,553 $466,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email